ROYAL LONDON ASSET MANAGEMENT LTD
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 863748
UNITED KINGDOM, X0
Position in REGN
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$3,027,976
-$229,315 QoQ
Shares Held
3,919
-7.1% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ROYAL LONDON ASSET MANAGEMENT LTD holds $495,689,061 across 9 Biotechnology names. REGN ranks #6 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
3,808,353 | $182,686,693 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
252,192 | $112,613,815 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
1,610,553 | $104,090,040 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
215,075 | $71,161,865 | |
| 5 | INCY |
Incyte Corp
|
192,049 | $18,075,651 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
3,919 | $3,027,976 | |
| 7 | INSM |
INSMED Inc
|
14,498 | $2,370,712 | |
| 8 | LEGN |
Legend Biotech Corp
|
75,000 | $1,356,750 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,027,976 | 3,919 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $3,257,291 | 4,220 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,534,150 | 4,507 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $24,449,775 | 46,571 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $31,478,103 | 49,632 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $31,402,355 | 44,084 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $45,912,907 | 43,675 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $44,692,948 | 42,523 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $39,519,839 | 41,060 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $36,579,900 | 41,649 | Shares | Sole | 2024-03-01 | |
| 2023-09-30 | $33,396,539 | 40,581 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $27,972,043 | 38,929 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $30,153,645 | 36,698 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $26,584,742 | 36,847 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $24,126,294 | 35,023 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $21,474,570 | 36,328 | Shares | Sole | 2022-09-06 | |
| 2022-03-31 | $25,151,501 | 36,012 | Shares | Sole | 2022-09-06 | |
| 2021-12-31 | $21,586,616 | 34,182 | Shares | Sole | 2022-10-18 | |
| 2021-09-30 | $21,050,581 | 34,784 | Shares | Sole | 2022-10-18 | |
| 2021-06-30 | $19,142,282 | 34,272 | Shares | Sole | 2022-10-18 | |
| 2021-03-31 | $17,094,548 | 36,130 | Shares | Sole | 2022-10-17 | |
| 2020-12-31 | $16,976,485 | 35,140 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $20,941,929 | 37,411 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $23,351,326 | 37,443 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $15,489,047 | 31,721 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||